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ABSTRACT  23 
Vibrio alginolyticus, a bacterial pathogen in fish and humans, expresses a type III 24 
secretion system (T3SS) that is critical for pathogen virulence and disease 25 
development. However, little is known about the associated effectors (T3SEs) and 26 
their physiological role. In this study, the T3SE gene hopPmaJ (hop) was cloned from 27 
V. alginolyticus wild-type strain HY9901 and the mutant strain HY9901∆hop was 28 
constructed by the in-frame deletion method. The results showed that the deduced 29 
amino acid sequence of V .alginolyticus HopPmaJ shared 78-98% homology with 30 
other Vibrio spp. In addition, the HY9901∆hop mutant showed an attenuated 31 
swarming phenotype and a 2600-fold decrease in the virulence to grouper. However, 32 
the HY9901∆hop mutant showed no difference in morphology, growth, biofilm 33 
formation and ECPase activity. Finally, grouper vaccinated via intraperitoneal (IP) 34 
injection with HY9901∆hop induced a high antibody titer with a relative percent 35 
survival (RPS) value of 84% after challenging with the wild-type HY9901.Real-time 36 
PCR assays showed that vaccination with HY9901∆hop enhanced the expression of 37 
immune-related genes, including MHC-Iα, MHC-IIα, IgM, and IL-1 β  after 38 
vaccination, indicating that it is able to induce humoral and cell-mediated immune 39 
response in grouper. These results demonstrate that the HY9901∆hop mutant could be 40 
used as an effective live vaccine to combat V. alginolyticus in grouper. 41 
Key words: Vibrio alginolyticus; T3SS; hopPmaJ; live attenuated vaccine; 42 
Epinephelus coioides 43 
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1. Introduction 45 
Vibrio alginolyticus，a Gram-negative motile rod bacterium, is the causative 46 
agent of Vibriosis which is a devastating fish disease prevailing in worldwide 47 
aquaculture industries and leads to extensive losses in a diverse array of  48 
commercially important fish including orange-spotted grouper (Epinephelus coioides), 49 
large yellow croaker (Larimichthys crocea), sea bream (Sparus aurata L), Kuruma  50 
prawn (Penaeus japonicus) and causes symptoms of septicemia, hemorrhaging, dark 51 
skin, and ulcers on the skin surface [1-4].Moreover, this pathogen has also been 52 
reported to cause diarrhea, otitis, and wound infections in humans [5-6]. Therefore, it 53 
is important to understand the pathogenesis of V. alginolyticus and to develop an 54 
efficacious vaccine to prevent Vibriosis. 55 
The type III secretion system (T3SS) is a highly conserved apparatus among 56 
several Gram-negative bacteria，such as Yersinia spp., Salmonella spp. and Shigella 57 
spp [7-9], which delivers bacterial proteins, known as effectors, directly into host cells 58 
[10]. Many of these effectors are virulence factors that can trigger host-cell death and 59 
manipulate the innate and adaptive immune system [11-12].Although the T3SS 60 
machinery is often conserved among Gram-negative pathogens, the effectors differ 61 
widely in their function. Comparative genome analysis has demonstrated that T3SS of 62 
V. alginolyticus is similar to T3SS1 of V. parahaemolyticus [13], but little is known 63 
about the effectors of V. alginolyticus. Therefore functional characterization of T3SS 64 
effectors is necessary. 65 
In a previous study, we identified a V. alginolyticus effector HopPmaJ [14], 66 
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which was homologue to the T3SEs HopPmaJ of Chryseobacterium gleum 67 
[15].However, its role in V. alginolyticus is still unknown. To better understand the 68 
function of HopPmaJ in the T3SS from V. alginolyticus, we first constructed a hop 69 
gene mutant, then investigated the physiology and pathogenicity of the ∆hop strain. 70 
Furthermore, we evaluated the immunoprotective potential of ∆hop, and found that 71 
the ∆hop mutant could be used as an effective live vaccine to combat V.alginolyticus 72 
in grouper. 73 
 74 
2. Materials and methods 75 
2.1 Bacterial strains and culture conditions 76 
The bacterial strains, plasmids and cell line used in this work are listed in Table 77 
1.V. alginolyticus wild-type strain HY9901 was isolated from Lutjanus 78 
erythopterus[16] and was utilized as the parent strain for constructing the deletion 79 
mutant ∆hop. V. alginolyticus was cultured on trypticase soy broth (TSB, Huankai Co 80 
Ltd., Guangzhou, China) or on 1.5% TSB agar plates (TSA) at 28℃. Escherichia coli 81 
strains were cultured in Luria-Bertani (LB, Huankai Co Ltd., Guangzhou, China) or 82 
on LB agar at 37℃. When required, the appropriate antibiotics were added: ampicillin 83 
(Amp, 100µgmL-1); kanamycin (Km, 50µg mL-1); chloramphenicol (Cm, 25µg mL-1). 84 
2.2 Orange-spotted Grouper 85 
E. coioides (average weight 20.0 ±2.0g) were obtained from a commercial fish 86 
farm in Zhanjiang, China, and kept in seawater in a circulation system at 26-27℃ for 87 
two weeks before experiment. Prior to the experiment, sera were taken randomly from 88 
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three fish and tested by slide agglutination against formalin-inactivated V. 89 
alginolyticus. Internal organs (spleen, liver, and kidney) of grouper were also 90 
collected and tested by bacteriological recovery tests. Fish that were negative in the 91 
sera agglutination and bacterial analysis were used in this study.  92 
2.3 Cloning and sequencing of the hop gene from V. alginolyticus HY9901 93 
A pair of primers hop1 and hop2 was designed as showed in Table 2 according to 94 
the V. alginolyticus gene sequence (GenBank Number: NZ_AAPS00000000). PCR 95 
was performed in a Thermocycler (Bio-Rad, CA, USA) under the following 96 
optimized amplification conditions: an initial denaturation at 94 ℃for 4 min, followed 97 
by 35 cycles of 94 ℃ for 30 s, 41℃ for 30 s and 72 ℃ for 30 s. 5 µL of each 98 
amplicon was examined on 1% agarose gels, stained with ethidium bromide. The PCR 99 
product was recovered from the agarose gel to ligate into the pMD18-T vector and 100 
transformed into E. coli DH5α (Table 1). The inserted fragment was sequenced by 101 
Sangon Biological Engineering Technology & Services Co., Ltd. (Shanghai, China). 102 
Similarity analyses of the determined nucleotide sequences and deduced amino acid 103 
sequences were performed by BLAST programs (http://blast.ncbi.nlm.nih.gov/ 104 
Blast.cgi) and aligned using the program Clustal-X (version 1.81). Protein analysis 105 
was conducted with ExPASy tools (http://expasy.org/tools/). Location of the domain 106 
was predicted using the InterProScan program (http://www.ebi.ac.uk/Tools 107 
/pfa/iprscan/). 108 
2.4 Construction of in-frame deletion mutant of hop gene 109 
Overlap extension PCR was applied to generate an in-frame deletion of the hop 110 
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gene on the V. alginolyticus wild-type HY9901 chromosome [17]. The in-frame 111 
deletion of hop in the V. alginolyticus was generated according to the method of 112 
Rubires et.al [18].For the construction of ∆hop, two PCR fragments were generated 113 
from HY9901 genomic DNA. The first fragment was amplified using primers hop-for114 
（contains a KpnI site at the 5’-end） and hop-int-rev；whereas primers hop-int-for 115 
and hop-rev（contains a SmaI site at the 5’-end ）were used to amplify the second 116 
fragment. Both fragments containing a 20bp overlapping sequence and used as 117 
templates for the subsequent PCR procedure, which used primers hop-for and hop-rev. 118 
The resulting PCR product, containing a deletion from amino acid (aa) 46-342 of hop, 119 
was ligated into suicide vector pRE112[19] (Cmr) to generate pRE-△hop. This 120 
recombinant suicide plasmid was transformed into E. coli MC1061λpir [18] and 121 
subsequently S17-1λpir[20]. The single crossover mutants were obtained by conjugal 122 
transfer of the resulting plasmid into V. alginolyticus HY9901. Deletion mutants were 123 
screened on 10% sucrose TSA plates. Its presence was subsequently confirmed by 124 
PCR and sequencing using primers hop-up and hop-down. 125 
2.5 Characterization of the △hop 126 
The ∆hop phenotype was characterized by cell morphology, growth ability, 127 
extracellular protease (ECPase) activity, biofilm formation, swarming motility, and 128 
fifty percent lethal dose (LD50). Briefly, the wild-type HY9901 strain and the ∆hop 129 
were cultured in TSB for 18 h, and cell morphology was observed by scanning 130 
electron microscopy. To measure the growth level of bacteria in TSB, overnight 131 
cultures of the wild-type HY9901 strain and ∆hop mutant were inoculated into TSB 132 
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with an initial OD600 of 0.01, respectively. Samples were removed every 1 h and the 133 
optical density was measured at 600 nm. Extracellular protease (ECPase) activity was 134 
performed according to the method of Windle and Kelleher [21]. Biofilm formation 135 
was assayed using the crystal violet stain method described previously [22]. 136 
Swarming motility was assayed using the method described by Mathew et al. [23]; 137 
swarming diameter was measured after 24h incubation. The cell adherence was 138 
performed as previously described [24-25]. Confluent monolayers of fathead minnow 139 
epithelial cell line (FHM) (Table 1) [26] grown in 24-well plates were infected with 140 
HY9901∆hop and HY9901, respectively. 141 
LD50 of the wild-type and ∆hop were evaluated in E. coioides. Briefly, twenty  142 
grouper were injected intraperitoneally with 100µL HY9901 or ∆hop suspended in 143 
sterile phosphate buffered saline (PBS) containing 104-109cfu mL-1 with an injection 144 
of 100µL sterile PBS serving as a negative control, respectively. The fish were 145 
monitored for 14 days, and any fish that died were removed for bacteriological 146 
examination. The experiment was performed twice, and the LD50 values were 147 
calculated by the statistical approach of Reed and Muench [27]. 148 
2.6 Preparation of formalin-killed cell (FKC) suspensions  149 
The V. alginolyticus FKC suspensions were produced as described by Zhou et al. 150 
[28]. Briefly, V. alginolyticus strain HY9901 was grown in TSB for 18 h. The cells 151 
were harvested by centrifugation at 5000×g for 10 min and suspended in 0.85% saline 152 
solution to 1×108cfu mL-1. Formaldehyde was then added at a final concentration of 1% 153 
to inactivate the bacteria for 3 days. The killed bacteria were washed three times and 154 
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resuspended in PBS to 1×108cfu mL-1. Confirmation of bacterial death was confirmed 155 
by incubating a culture for 48 h at 28 ℃ on TSA, and stored at -4℃ until use. 156 
2.7 E. coioides vaccination 157 
E. coioides were randomly divided into three groups with 80 fish per group. 158 
Prior to vaccination, the fish were anaesthetized by immersion in a 20 mg L-1 solution 159 
of tricainemethanesulfonate (MS-222, Sigma). Fish in the HY9901∆hop group were 160 
injected intraperitoneally with 100µL 1×105cfu mL-1∆hop. Fish in the FKC group 161 
were injected intraperitoneally with 100µL 1×108cfu mL-1 FKC as previously 162 
described[28] .Control fish were injected intraperitoneally with 100 µL sterile PBS. 163 
All of fish were maintained at 26-28℃. The experiment was repeated three times. 164 
2.8 Investigation of the livability of HY9901∆hop in vivo post vaccination 165 
The fish injected intraperitoneally with 100µL 1×105cfu mL-1HY9901∆hop 166 
extended to 7 days post vaccination. The organs including spleen and head-kidney 167 
were aseptically collected from day 1 to day 7. All the samples were weighed and 168 
homogenized in 1 ml PBS. The homogenates were serially diluted and plated in 169 
triplicate onto TCBS plates and incubated at 28℃ for 18 h. The bacteria counts were 170 
calculated by dividing the weights of the tissues and from the mean of three samples. 171 
2.9 Analysis of antibody levels 172 
During the experimental period from one to eight weeks post-vaccination, E. 173 
coioides serum-pools (from 3 fish) of each group were collected in order to measure 174 
antibody levels using ELISA as previously described [29].Microtiter plate wells were 175 
coated with 100 µL of V. alginolyticus FKC by overnight incubation at 4℃.Excess 176 
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cells were discarded, and wells were blocked with 100 µL of PBS containing 2% 177 
bovine serum albumin (BSA) for 3 h at 22℃. After removing the blocking solution 178 
and washing three times with PBS added with 0.05% Tween-20 (PBST), the wells 179 
were incubated for 3 h at 22 ℃ with 100 µL of serially diluted E. coioides serum. 180 
Antibody binding to the antigen was detected using E. coioides IgM monoclonal 181 
antibody (1:10000) which was produced according to Li et al. [30], followed by rabbit 182 
anti-mouse IgG-HRP (Wuhan Boster, Wuhan, China) at 1:20000 dilution, and colour 183 
was developed with a chromogenic reagent TMB (tetrame-thylbenzidine) (Amresco, 184 
Ltd,MA, USA) for 20 min with the reaction being stopped by the addition of 2.0 M 185 
H2SO4. The plates were then read at 450 nm with a microplate reader (Bio-Rad, 186 
Hercules, CA, USA). Sera were considered positive for anti-V. alginolyticus specific 187 
antibodies if the absorbance was at least double of the control sera, and antibody titers 188 
were scored as the highest positive dilution. . 189 
2.10Immune-related gene expression analysis 190 
Kidney and spleen samples were taken from three fish from each group 191 
respectivetly at 1 day before challenge. Immune-related genes expression levels were 192 
detected with real-time PCR. Primers for MHC-Iα, MHC-IIα, IgM, and IL-1β are 193 
shown in Table 2. β-actin was used as internal reference. The procedures of RNA 194 
extraction, cDNA synthesis, real-time PCR for analysis of immune gene expression 195 
were described by Li et al. [31]. 196 
2.11 Challenge experiment. 197 
Four weeks post immunization, E. coioides (n=30) were anesthetized and 198 
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challenged separately by IP inoculation of 100µL 1×108cfu mL-1 of V. alginolyticus 199 
HY9901 [28]. The relative percent survival (RPS) of post-challgenged fishes were 200 
measured per day in a 14-days time frame as previously described [32].  201 
2.12 Statistical Analysis 202 
Statistical analyses were performed using SPSS 17.0 (SPSS Inc., USA). The data 203 
obtained from analyses of bacterial counts, swarming diameter, biofilm formation, 204 
cell adherence, and agglutination titers were shown as X±SD, and the statistical 205 
significance of differences between the wild-type strain and ∆hop mutant, were 206 
determined using the Student's t-test. Group differences were determined by Duncan’s 207 
test. Data was considered statistically significant when p<0.05 . 208 
3. Results 209 
3.1 Cloning and mutagenesis of hop in V. alginolyticus HY9901 210 
The hop gene consisted of an open reading frame of 345 bp encoding 114 amino 211 
acids with a predicted molecular mass of 12.78 kDa and a theoretical isoelectric point 212 
of 4.45. The nucleotide sequence of HY9901 hopPmaJ was deposited in the GenBank 213 
database under the accession number KX245315. Blast of deduced amino acid of 214 
HopPmaJ indicated that it has 78-98% identity with other Vibrio spp. And it shared 215 
the highest homology to HopPmaJ of Vibrio parahemolyticus (98%), which located in 216 
T3SS2. However, the role of HopPmaJ in V. parahaemolyticus has not been reported 217 
(Fig. 1). 218 
To understand possible roles of HopPmaJ in V. alginolyticus, an unmarked hop 219 
deletion mutant was constructed by using overlap PCR and a double-selection strategy. 220 
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The mutant was confirmed by inability to grow on TSA supplemented with 221 
chloramphenicol, and verified by PCR by generating a fragment of approximately 655 222 
bp (Fig.2). 223 
3.2 Morphology, growth, activity of ECPase, biofilm formation, swarming motility, 224 
and the LD50 of HY9901∆hop 225 
Morphology was assessed by scanning electron microscopy. HY9901∆hop 226 
showed no discernible morphological difference from HY9901 when cultured in TSB 227 
(Fig.3). HY9901∆hop showed similar growth as the wild-type strain when cultured in 228 
TSB medium (Fig.4).  229 
Biofilm formation is a multicellular behavior by which bacteria colonize surface 230 
of host tissue, leading to resistance to antibiotics and host immune-killing [33-34]. 231 
However, in the investigation of biofilm formation, we found there was no difference 232 
between the HY9901∆hop and wild-type strain HY9901 during the incubation. The 233 
results indicated that hop gene may not have a role in the biofilm development of V. 234 
alginolyticus (Table 3). 235 
ECP is a crucial virulence factor, and the activity of ECPase showed no 236 
difference between HY9901∆hop and the wild-type strain (p>0.05). HY9901∆hop 237 
showed a smaller swarming diameter than HY9901 (p<0.01) (Table 3). 238 
 The adherence rate (0.88%) of the HY9901∆hop was 2 fold lower than that of 239 
the HY9901 (1.77% )(p<0.01).This result indicates that the hopPmaJ gene may 240 
regulate the transcription of genes encoding cell surface components involved in the 241 
adhesion of V. alginolyticus to epithelial cells (Table 3). 242 
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LD50 levels of HY9901∆hop were 3 logs higher than that of HY9901 (p< 0.01). 243 
All of the dead fish exhibited the clinical symptoms of Vibriosis such as ulcers on the 244 
skin, hemorrhagic and swelling in the liver and kidney. Bacteria were re-isolated from 245 
the ulcers of the skin, liver and kidney of the grouper and identified as V. alginolyticus 246 
by 16S rDNA sequencing. No disease signs or mortalities were detected within 2 247 
weeks following challenge of the fish with doses less than 105cfu mL-1 of 248 
HY9901∆hop. HY9901∆hop has almost no side effects in terms of growth 249 
performance in E. coioides, when doses less than 105cfu mL-1. These results indicated 250 
that the hop gene contributes to the pathogenesis of V. alginolyticus (Table 3). 251 
3.3 Investigation of the livability of HY9901∆hop in vivo 252 
HY9901∆hop was able to disseminate into but survive transiently in fish 253 
head-kidney and spleen then was gradually eliminated from the host body (Fig. 5). 254 
The highest bacterial number was detected in spleen on day 3, followed by the 255 
head-kidney.  256 
3.4 Analysis of antibody levels 257 
Grouper (E. coioides) were immunized with two different types of V. 258 
alginolyticus vaccines, HY9901∆hop and FKC. The immune response of grouper was 259 
assessed by ELISA at week 1, 2, 3, 4, 5, 6, 7 and 8 after vaccination (Fig. 6). The 260 
result indicated that the specific antibody titers of fish immunized with FKC and 261 
HY9901∆hop were markedly higher than those of in the control group (p < 0.05). In 262 
the immunized group the antibody titer reached the highest level at week 4 (p< 0.01). 263 
Compared to the FKC group, HY9901∆hop vaccinated group had significantly greater 264 
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titer of E. coioides specific serum antibodies from week 3 pv (p< 0.01). 265 
3.5 Immune gene expression in E. coioides following vaccination with HY9901∆hop 266 
qRT-PCR was carried out to analyze the transcription levels of genes encoding 267 
MHC-Iα, MHC-IIα, IgM and IL-1β. The results showed that compared to FKC 268 
injection, vaccination with HY9901∆hop significantly increased the expression of 269 
IL-1β, MHC Iα, MHC IIα and IgM genes in the spleen and head kidney (p < 0.01) 270 
(Fig. 7). MHC-Iα and MHC-IIα are respectively responsible for humoral and cellular 271 
mediated immunity. As proinflammatory factor, IL-1βcan induce the inflammatory 272 
response. Taken together, all of the above results suggested that HY9901∆hop can 273 
effectively elicit protective immune responses in E. coioides. 274 
3.6 Immune protective effects of HY9901∆hop in E. coioides 275 
E. coioides were vaccinated with FKC and HY9901∆hop by intraperitoneal 276 
injection, and challenged with the wild type HY9901 30 days pv. As shown in Fig. 8, 277 
mortality in the control group administered PBS was 77.5%; whereas grouper 278 
vaccinated with the HY9901∆hop had low cumulative mortality of 12.5 %with a RPS 279 
of 84 % (p < 0.05), and fish vaccinated with FKC had a RPS of 71%. 280 
 281 
4. Discussion 282 
Although the T3SS of V. alginolyticus is similar to T3SS1 of V. parahaemolyticus 283 
with respect to gene synteny [13], it is unclear if the same regulatory mechanism is 284 
employed by V. alginolyticus. As one of the T3SE, the hopPmaJ could play a crucial 285 
role required for efficient attack in the host. This study included a characterization of 286 
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the physiology and pathogenicity of the T3SE gene hopPmaJ in V. alginolyticus. 287 
Production of extracellular products (ECP) mainly including protease, hemolysin 288 
and siderophore, are thought to be characteristics of the virulent strain of V. 289 
alginolyticus[16,35]. Biofilm formation is a multicellular behavior by which bacteria 290 
colonize the surface of host tissue, leading to resistance to antibiotics and host 291 
immune responses [33-34]. Nevertheless, our results indicated that there was no 292 
significant difference between HY9901 and HY9901∆hop in morphology, growth, 293 
biofilm, and ECP. Therefore, hop may not be responsible for these characteristics in 294 
V.alginolyticus. 295 
The flagella contributing to the swarming motilities could help bacteria access an 296 
appropriate niche inside the host after Vibrio infection [36]. Quite a few studies have 297 
shown that flagellin is essential for virulence, flagellum forming, normal motility and 298 
symbiotic competence during initial squid light organ colonization of Vibrio [37]. In 299 
the present study, the hop mutant of V. alginolyticus had suppressed swarming motility. 300 
The results suggested that hop is a positive contributor to swarming motility in V. 301 
alginolyticus, and might function indirectly through regulating the expression level of 302 
fla, however this needs further investigation. 303 
The first step of the bacterial infection is the adherence of bacteria to the surface 304 
of host epithelial cells, which facilitates colonization on or penetration of the cells [38] 305 
In the current study, we tested if V. alginolyticus hop contributes to bacterial adhesion 306 
to FHM cells. The data from this work showed that the adherence rate (0.88%) of the 307 
HY9901∆hop was significantly lower than that of the HY9901 (1.77%) (p<0.01), 308 
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indicating hop is required for adhesion to FHM cells.  309 
Several similar studies have demonstrated that mutants with deletion of T3SS 310 
effectors encoding genes display decreased virulence in mice, poultry, pigs, and 311 
humans [32, 39]. Furthermore a number of studies have shown that mutants deficient 312 
in the production of T3SE could induce high levels of long lasting protection against 313 
pathogeny [40-41]. In the current study, the LD50 of HY9901∆hop was 3 logs higher 314 
than that of wild-type HY9901 and showed low or no lethality virulence in E. 315 
coioides when administered via i.p. injection (Table 3 and data not shown). Moreover 316 
our findings also show that HY9901∆hop has almost no side effects in terms of 317 
growth performance in E. coioides. We evaluated the efficacy of HY9901∆hop as a 318 
live attenuated vaccine (LAV) by injection route in an E. coioides model, resulting in 319 
a RPS of 84% 4-week post vaccination. The significantly enhanced specific antibody 320 
confirmed the immune responses in E. coioides.  321 
It has already been confirmed that live attenuated vaccines can induce a more 322 
robust humoral and cell-mediated immune response than killed bacteria [42]. The 323 
increase of MHC Ι expression in the spleens was also found in golden pompano 324 
vaccinated with a Streptococcus agalactiae phoB mutant[43].MHC II is displayed on 325 
surface of antigen presenting cells (APC) to activate T-help cells to regulate immune 326 
network[44]. IL-1 β , an important pro-inflammatory cytokine, can induce the 327 
inflammatory response by regulating the expression of other cytokines. Xiao et al. 328 
[40]. IgM gene expression can be induced by intraperitoneal injection with Yersinia 329 
ruckeri in rainbow trout [45].In this study, the elevated expression of immune-related 330 
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genes (MHC-Iα, MHC-IIα, IgM, and IL-1β), confirmed the stimulation of innate and 331 
acquired immune responses in E. coioides. Future work using immunohistochemical 332 
methods or flow cytometry sorting rather than qRT-PCR will further provide a deeper 333 
understanding of the protective immune mechanisms of HY9901∆hop in E. coioides 334 
or other fish. 335 
In conclusion, we have successfully constructed an in-frame deletion strain of 336 
HY9901∆hop and investigated its physiology and pathogenicity. HY9901∆hop 337 
exhibited a high level of protection against virulent V. alginolyticus challenge, and 338 
could elicit both humoral and cell-mediated immune responses in E. coioides. These 339 
results may provide further evidence for the importance of T3SE in V. alginolyticus 340 
and serve as a reference for further investigation on this virulence factor 341 
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 507 
Table 1 Bacterial strains, plasmids and cell line used in this study 508 
Strains , plasmids , cell line Relevant characteristics Source or 
references 
V. alginolyticus HY9901 Wild type, isolated from diseased Lutjanus 
sanguineus off the Southern China coast 
[16] 
∆hop HY9901 carrying an in-frame deletion of 
hop46-342 
This study 
E. coli DH5α supE44 ∆lacU169 (φ80 lacZDM15) hsdR17 
recA1 gyrA96 thi-1 relA1 
Sangon 
MC1061 (λpir) lacY1 galK2 ara-14 xyl-5 supE44 λpir [18] 
pRE112 pGP704 suicide plasmid, pir dependent, oriT, 
oriV, sacB, Cmr 
[19] 
S17-1 (λpir) Tpr Smr recA thi pro hsdR－M＋RP4 :2-Tc : Mu: 
Km Tn7 λpir 
[20] 
MC1061-pRE-∆hop MC1061 containing plasmid of pRE-∆hop, Cmr This study 
S17-1-pRE-∆hop S17-1 containing plasmid of pRE-∆hop, Cmr This study 
pMD18-T Cloning vector, Ampr TakaRa 
pRE-∆hop pRE112 containing hop gene in-frame deletion 
of codons 46-342, Cmr 
This study 
FHM fathead minnow epithelial cell; PenR; StrepR [26] 
 509 
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 511 
Table 2 Sequences of primers used in this study. 512 
Primer name Primer sequence(5’-3’) references 
Cloning 
primers 
 
 
hop1 TTA TTT AGC GGT TAA A  This study 
hop2 ATG GAA TTA AAA TCG This study 
Mutant 
construction 
 
 
hop-for GGGGTACCATGAACACGCGATGG(Kpn I) This study 
hop-int-rev CTCTGGTGACGCTGCCAATACATCGTTTTCTGACTGGTGTTTA This study 
hop-int-for TATTGGCAGCGTCACCAGAGTAAACACCAGTCAGAAAACGATG This study 
hop-rev CCCCCGGG TCGAGCAGCATGTA(Sma I) This study 
hop -up TAAACTTCGTTGCTACCGCC  This study 
hop -down AAACTTAATGCCTTCCCACC This study 
qPCR 
primers 
 
 
MHC-IαF GCCGCCACGCTACAGGTTTCTA This study 
MHC-IαR TCCATCGTGGTTGGGGATGATC This study 
MHC-IIαF GGAGCCTCAGCCCAGCTTCA This study 
MHC-IIα R CCAGTGGGAGGTCCTTCATG This study 
IgM F TACAGCCTCTGGATTAGACATTAG This study 
IgM R CTGCTGTCTGCTGTTGTCTGTGGAG This study 
IL-1β- F ACACGGCTTTGTCGTCTTTC This study 
IL-1β- R ACGCTGCTGGACCTTTATCG This study 
β-actin F AAATCGCCGCACTGGTTG This study 
β-actin R TCAGGATACCCCTCTTGCTCT This study 
 513 
 514 
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 517 
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 524 
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 527 
Table 3 Characteristics of HY9901∆hop 528 
Characteristics HY9901 HY9901∆hop 
Activity of ECPase (A442)a 0.08±0.01 0.11±0.01 
Biofilm formationb 
0.32±0.06 0.36±0.15 
Swarming (mm)c 
45±0.15 23±0.5** 
Adherence rate (%)d 
1.77±0.11 0.88±0.25** 
LD50 (cfu mL-1)e 2.5×105 6.5×108** 
Values are mean ± standard deviation for three trials. Significant differences between 529 
HY9901 and HY9901∆hop indicated by asterisk. **p <0.01. 530 
a  Bacteria were incubated in TSB for 18 h at 28℃. 531 
b  Bacteria were incubated in 96-well polypropylene plates for 48 h at 28℃. 532 
c  Swarming diameters were measured after 24 h incubation on TSA containing 0.3% 533 
agar plates. 534 
d Adherence rate were expressed as percentage of observed CFU relative to the total 535 
input bacteria.  536 
e  LD50 were evaluated in healthy E. coioides with an average weight of 20.0 ±2g. 537 
 538 
 539 
 540 
 541 
 542 
 543 
 544 
 545 
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 548 
Figure legends 549 
Figure 1 Homology comparison of V.alginolyticus HY9901 T3SS Effector Protein HopPmaJ 550 
V.alginolyticus HY9901 T3SS Effector Protein HopPmaJ; V. alginolyticus NBRC 15630 = ATCC T3SS 551 
Effector Protein HopPmaJ Accession NC_022359.1 WP_005375560.1; V.parahaemolyticus serotype 552 
O3:K6 (strain RIMD 2210633) T3SS Effector Protein; V.harveyi CMCP6-E0666 T3SS Effector Protein; 553 
V. genomosp.T3SS Effector Protein，niRef90_UPI000474712C; V.coralliilyticus T3SS Effector Protein，554 
niRef90_U0ESZ4; V.vulnificus. T3SS Effector Protein HopPmaJ, UniRef90_E8VUS9; V. orienta T3SS 555 
Effector Protein HopPmaJ, UniRef90_C9QFQ5; Flavobacterium T3SS Effector Protein, 556 
UniRef90_UPI00047A9F35 557 
 558 
Figure 2 Construction and confirmation of the knockout mutant strain HY9901∆hop  559 
M: DL2000 marker; Lane 1. The 313bp upstream fragment amplified from genomic DNAs of the 560 
wild-type strain HY9901using primer pairs of hop-for / hop-int-rev. Lane 2. The 342bp downstream 561 
fragment amplified from genomic DNAs of the wild-type strain HY9901using primer pairs of 562 
hop-int-for / hop-rev.Lane 3. The 655 bp fragment amplified from genomic DNAs of HY9901∆hop 563 
using primer pairs of hop-for / hop-revLane 4. The 952 bp fragment amplified from genomic DNAs of 564 
the wild-type strain HY9901using primer pairs of hop-for / hop-rev. 565 
 566 
Figure 3 Observation the morphological feature of HY9901(A) and HY9901∆hop (B)by SEM. 567 
 568 
Figure 4 Growth features of HY9901∆hop and HY9901. Aliquots of cell culture were taken at various 569 
time points and measured for cell density at OD600. 570 
 571 
Figure 5 Propagation of HY9901∆hop in grouper kidney (A) and spleen (B) following i.p. injection 572 
with 100µL 1×105cfu mL-1∆hop. Control fish were i.p. injection with 100 µL sterile PBS The number 573 
of viable bacteria was shown as the mean ± standard of three samples.  574 
 575 
Figure 6 Antibody titers in sera of grouper injected IP with HY9901∆hop, FKC and PBS. Sera 576 
collected at week 1to 8 post-vaccination were assayed by ELISA. Each column represents the mean of 577 
log 2 antibody titer with standard deviation bar. Groups that do not share a letter are significantly 578 
different (p < 0.01). 579 
 580 
Figure 7.The head kidney and spleen of grouper were sampled at 1 day before challenge, and total 581 
RNA was extracted for qRT-PCR. The mRNA level of each immune-related gene was normalized to 582 
that of	β-actin. Bars represent the mean relative expression of three biological replicates and error bars 583 
represent standard deviation. Groups that do not share a letter are significantly different (p < 0.01). 584 
 585 
Figure 8 Percent survival in groups vaccinated with HY9901∆hop, FKC and PBS following challenge 586 
with Vibrio alginolyticus HY9901. 587 
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Fig. 1 591 
 592 
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The biological functions of HopPmaJ in alginolyticus were investigated.  
HY9901∆hop suppressed swarming motility, adhesion and virulence. 
The RPS of grouper vaccinated with HY9901∆hop was 84 %. 
HY9901∆hop could stimulate innate and acquired immune responses in E. coioides. 
 
